Table 1: Socio-demographic and clinical characteristics of study population.

Characteristics

Haemodialysis

N = 13

Not on dialysis

N = 15

Total (%)

N = 28

Age (year)

 

 

 

< 40

2

0

2(7.1)

[40-59]

6

2

8(28.6)

[60-79]

5

12

17(60.7)

≥ 80

0

1

1(3.6)

Gender

 

 

 

Male

8

9

17(60.7)

Female

4

7

11(39.3)

Comorbidities

 

 

 

HTA

12

14

26(92.9)

Diabetes

4

9

13(46.4)

HIV

1

1

2(7.1)

Cirrhosis

5

7

12(43)

Compensated

4

5

9(75)

Decompensated

1

2

3(25)

Baseline nephropathy

 

 

 

Chronic tubulointerstitial nephritis

2

0

2(7.2)

Ischemic nephropathy

1

2

3(10.7)

Diabetic nephropathy

0

3

3(10.7)

Nephroangiosclerosis

3

1

4(14.3)

Chronic glomerulonephritis

4

3

7(25)

Indeterminate nephropathy

3

6

9(32.1)

HCV therapeutic status

 

 

 

Naive

13

14

27(96.4)

Relapse (INF-Peg / RBV)

0

1

1(3.6)

Mean duration in haemodialysis (months)

63.1 ± 37.7

/

/

Virological status at dialysis initiation

 

 

 

Positive

1(7.7)

/

/

Negative

10(76.9)

/

/

Unknown

2(15.4)

/

/

Median age of HCV diagnosis

/

/

6 [3-8.5]

HTA: Hypertension; HIV: Human Immunodeficiency Virus; INF-Peg: Pegylated interferon; RBV: ribavirin